HIF1α upregulation is important in the survival and angiogenic activity of radioresistant lung cancer cells, a situation where Hsp90 inhibitor treatment suppresses the HIF1α/Hsp90 interaction and HIF1α expression [91]. Here, HSP90AB1 is linked to lung cancer.